Completed NA INTERVENTIONAL 3-arm NCT01156376

Oral Irritation Study of Two Experimental Mouthrinses

Determination of the Oral Irritation and Sensitization Potential of Two Experimental Potassium Oxalate Containing Mouthrinses

Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide

Conditions Oral Manifestations

Interventions Active Comparator PO-116-A Potassium Oxalate with Fluoride Potassium Oxalate without Fluoride

Updated 6 times since 2017 Last updated: Aug 5, 2015 Started: Jun 30, 2010 Primary completion: Jul 31, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01156376, this NA trial focuses on Oral Manifestations and remains completed. Sponsored by Johnson & Johnson Consumer and Personal Products Worldwide, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jun 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Johnson & Johnson Consumer and Personal Products Worldwide

Data source: Johnson & Johnson Consumer and Personal Products Worldwide

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Wayne, United States